University of Toronto Transplant Institute, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
Cell Mol Immunol. 2012 Mar;9(2):136-46. doi: 10.1038/cmi.2011.62. Epub 2012 Feb 6.
Trogocytosis is a process which involves the transfer of membrane fragments and cell surface proteins between cells. Various types of T cells have been shown to be able to acquire membrane-bound proteins from antigen-presenting cells and their functions can be modulated following trogocytosis. However, it is not known whether induced regulatory T cells (iTregs) can undergo trogocytosis, and if so, what the functional consequences of this process might entail. In this study, we show that iTregs can be generated from CD80(-/-)CD86(-/-) double knockout (DKO) mice. Using flow cytometry and confocal fluorescence microscopy, we demonstrate that iTregs generated from DKO mice are able to acquire both CD80 and CD86 from mature dendritic cells (mDCs) and that the acquisition of CD86 occurs to a higher extent than that of CD80. Furthermore, we found that after co-incubation with iTregs, dendritic cells (DCs) downregulate their surface expression of CD80 and CD86. The trogocytosis of both CD80 and CD86 occurs in a cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), CD28 and programmed death ligand-1 (PDL1)-independent manner. Importantly, we showed that iTregs that acquired CD86 from mDCs expressed higher activation markers and their ability to suppress naive CD4(+) T-cell proliferation was enhanced, compared to iTregs that did not acquire CD86. These data demonstrate, for the first time, that iTregs can acquire CD80 and CD86 from mDCs, and the acquisition of CD86 may enhance their suppressive function. These findings provide novel understanding of the interaction between iTregs and DCs, suggesting that trogocytosis may play a significant role in iTreg-mediated immune suppression.
细胞融合是一种涉及细胞间膜片段和细胞表面蛋白转移的过程。已经证明,各种类型的 T 细胞能够从抗原呈递细胞获得膜结合蛋白,并且在细胞融合后其功能可以被调节。然而,目前尚不清楚诱导性调节性 T 细胞(iTregs)是否能够发生细胞融合,如果可以,这个过程的功能后果可能是什么。在这项研究中,我们表明,iTregs 可以从 CD80(-/-)CD86(-/-)双敲除(DKO)小鼠中产生。通过流式细胞术和共聚焦荧光显微镜,我们证明了从 DKO 小鼠中产生的 iTregs 能够从成熟树突状细胞(mDCs)中获得 CD80 和 CD86,并且 CD86 的获得程度高于 CD80。此外,我们发现,在与 iTregs 共孵育后,树突状细胞(DCs)下调其表面 CD80 和 CD86 的表达。细胞融合发生在细胞毒性 T 淋巴细胞相关抗原-4(CTLA-4)、CD28 和程序性死亡配体-1(PDL1)独立的方式下。重要的是,我们表明,从 mDC 获得 CD86 的 iTregs 表达更高的活化标志物,并且它们抑制幼稚 CD4(+)T 细胞增殖的能力增强,与未获得 CD86 的 iTregs 相比。这些数据首次表明,iTregs 可以从 mDC 获得 CD80 和 CD86,并且获得 CD86 可能增强其抑制功能。这些发现为 iTregs 和 DC 之间的相互作用提供了新的认识,表明细胞融合可能在 iTreg 介导的免疫抑制中发挥重要作用。